This page is translated by Google and can contain errors. Go back to English.
  1. Home
  2. News

News

Cancer knows no boundaries, and neither do we

Nitroglycerin as a radiosensitizer in non-small cell lung cancer: Results of a prospective imaging-based phase II trial

Bart J.T. Reymen, Marike W. van Gisbergen, Aniek J.G. Even, Catharina M.L. Zegers, Marco Das, Erik Vegt, Joachim E. Wildberger, Felix M. Mottaghy, Ala Yaromina, Ludwig J. Dubois, Wouter van Elmpt, Dirk De Ruysscher, Philippe Lambin - Nitroglycerin as a radiosensitizer in non-small cell lung cancer: Results of a prospective imaging-based phase II trial. Clinical and Translational Radiation Oncology, 21 (49-55), DOI: 10.1016/j.ctro.2019.12.002

On-Label or Off-Label? Overcoming Regulatory and Financial Barriers to Bring Repurposed Medicines to Cancer Patients

Ciska Verbaanderd, Ilse Rooman, Lydie Meheus, Isabelle Huys - On-Label or Off-Label? Overcoming Regulatory and Financial Barriers to Bring Repurposed Medicines to Cancer Patients. Frontiers in Pharmacology, 31 January 2020, DOI: 10.3389/fphar.2019.01664

Transparancy of clinical trial reports assured

Clinical trials should remain transparent

Biased by design? Clinical trials and patient benefit in oncology

Pan Pantziarka, Ciska Verbaanderd, Lydie Meheus - Biased by design? Clinical trials and patient benefit in oncology. Future Medicine, 16 (3), doi.org/10.2217/fon-2019-0763